Janux Therapeutics
JANX
JANX
50 hedge funds and large institutions have $381M invested in Janux Therapeutics in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2% less capital invested
Capital invested by funds: $388M → $381M (-$7.13M)
6.16% less ownership
Funds ownership: 75.66% → 69.5% (-6.2%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
50
Holding in Top 10
–
Calls
$804K
Puts
$21K
Top Buyers
| 1 | +$3.97M | |
| 2 | +$1.39M | |
| 3 | +$757K | |
| 4 |
Millennium Management
New York
|
+$526K |
| 5 |
E
Ergoteles
New York
|
+$416K |
Top Sellers
| 1 | -$27.4M | |
| 2 | -$8.45M | |
| 3 | -$1.94M | |
| 4 |
Morgan Stanley
New York
|
-$1.63M |
| 5 |
Cerity Partners
New York
|
-$1.43M |